Related Experiment Video
Updated: Apr 8, 2026

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Pulmonary sarcoidosis in a preschool patient
Shivanthan Shanthikumar1, Jo Harrison1
1Respiratory Department, Royal Children's Hospital, Melbourne, Australia.
Insights
Pediatric pulmonary sarcoidosis is rare in preschoolers, typically affecting eyes, joints, and skin. This case highlights successful treatment of lung-only sarcoidosis in a 4-year-old using intravenous pulse methylprednisolone.
Area of Science:
- Pediatric Pulmonology
- Rheumatology
- Immunology
Background:
- Sarcoidosis is a rare multisystem granulomatous disease.
- Preschool sarcoidosis commonly involves eyes, joints, and skin, sparing the lungs.
- Oral prednisolone is the standard first-line treatment for pediatric sarcoidosis.
Observation:
- A 4-year-old boy presented with isolated pulmonary sarcoidosis, a rare presentation for this age group.
- The patient exhibited no involvement of other organs, such as eyes, joints, or skin.
- Standard treatment protocols for pediatric sarcoidosis were considered.
Findings:
- The child was successfully treated with intravenous pulse methylprednisolone followed by oral prednisolone.
- This treatment regimen resulted in a positive clinical outcome.
- The case demonstrates a novel and effective approach to managing pediatric pulmonary sarcoidosis.
Implications:
- This case expands the understanding of rare preschool sarcoidosis presentations.
- Intravenous pulse methylprednisolone offers a potentially effective treatment for pediatric pulmonary sarcoidosis.
- Further research into novel treatment strategies for early-onset sarcoidosis is warranted.
Abstract:
Sarcoidosis is a rare disease, especially in the preschool age group where it usually presents with eye, joint, and skin involvement sparing the lungs. Multiple treatment regimes have been described with oral prednisolone being the usual first line treatment. We describe a case of a 4-year-old boy presenting with pulmonary sarcoidosis with no other organ involvement. The child was successfully managed with pulse intravenous methylprednisolone followed by oral prednisolone and has had a good outcome. This case reports a rare presentation of preschool sarcoidosis as well as the novel and successful use of pulse methylprednisolone in paediatric pulmonary sarcoidosis.
Related Concept Videos
Other Pulmonary Disorders
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Cycle: Exhalation
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

